0001140361-15-017156.txt : 20150501
0001140361-15-017156.hdr.sgml : 20150501
20150501120456
ACCESSION NUMBER: 0001140361-15-017156
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150501
DATE AS OF CHANGE: 20150501
EFFECTIVENESS DATE: 20150501
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-239002
FILM NUMBER: 15822900
BUSINESS ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-681-5252
MAIL ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
D
1
primary_doc.xml
X0707
D
LIVE
0001527599
Mirna Therapeutics, Inc.
2150 WOODWARD ST., SUITE 100
AUSTIN
TX
TEXAS
78744
512-681-5252
DELAWARE
None
None
Corporation
true
Paul
Lammers
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Executive Officer
Director
Jon
Irvin
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Executive Officer
Sinil
Kim
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Executive Officer
Casi
DeYoung
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Executive Officer
Matthew
Winkler
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Clay
Siegall
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Michael
Powell
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Larry
Alleva
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Corey
Goodman
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Elaine
Jones
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Ed
Mathers
c/o Mirna Therapeutics, Inc.
2150 Woodward St.
Austin
TX
TEXAS
78744
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-03-31
false
true
false
0
45000000
41789527
3210473
false
24
0
0
0
false
Mirna Therapeutics, Inc.
/s/ Jon Irvin
Jon Irvin
Chief Financial Officer
2015-05-01